# An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas

> **NCT03460782** · — · NO_LONGER_AVAILABLE · sponsor: **Center Trials & Treatment**

## Conditions studied

- Glioblastoma
- Glioma of Brain

## Interventions

- **BIOLOGICAL:** Ipilimumab

## Key facts

- **NCT ID:** NCT03460782
- **Lead sponsor:** Center Trials & Treatment
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2019-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03460782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03460782, "An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03460782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*